U.K. Medicines And Healthcare Products Regulatory Agency Approves Oral Liquid Form Of Triheptanoin For Treatment Of Adult And Paediatric Patients With Long-Chain Fatty Acid Oxidation Disorders

뉴스 본문을 불러오고 있어요.

U.K. Medicines And Healthcare Products Regulatory Agency Approves Oral Liquid Form Of Triheptanoin For Treatment Of Adult And Paediatric Patients With Long-Chain Fatty Acid Oxidation Disorders | 웨이프 WAPE

U.K. Medicines And Healthcare Products Regulatory Agency Approves Oral Liquid Form Of Triheptanoin For Treatment Of Adult And Paediatric Patients With Long-Chain Fatty Acid Oxidation Disorders

기사 요약

관련 종목

댓글 —